10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2015 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 12, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Net product sales | $ 14,045 | 11,660 | 12,304 |
| Alliance and other revenues | 2,515 | 4,219 | 4,081 |
| Total Revenues | 16,560 | 15,879 | 16,385 |
| Cost of products sold | 3,909 | 3,932 | 4,619 |
| Marketing, selling and administrative | 4,841 | 4,822 | 4,939 |
| Research and development | 5,920 | 4,534 | 3,731 |
| Other (income)/expense | (187) | 210 | 205 |
| Total Expenses | 14,483 | 13,498 | 13,494 |
| Earnings Before Income Taxes | 2,077 | 2,381 | 2,891 |
| Provision for Income Taxes | 446 | 352 | 311 |
| Net Earnings | 1,631 | 2,029 | 2,580 |
| Net Earnings Attributable to Noncontrolling Interest | 66 | 25 | 17 |
| Net Earnings Attributable to BMS | 1,565 | 2,004 | 2,563 |
| Earnings per Common Share | |||
| Basic Earnings Per Common Share Attributable to BMS | 0.94 | 1.21 | 1.56 |
| Diluted Earnings per Common Share Attributable to BMS | 0.93 | 1.20 | 1.54 |
| Cash dividends declared per common share | 1.49 | 1.45 | 1.41 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2015 | |||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 12, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] | |||
| Net Earnings | $ 1,631 | 2,029 | 2,580 |
| Other Comprehensive Income (Loss), net of taxes and reclassifications to earnings [Abstract] | |||
| Derivatives qualifying as cash flow hedges | (51) | 69 | 7 |
| Pension and postretirement benefits | 101 | (324) | 1,166 |
| Available-for-sale securities | (54) | 3 | (37) |
| Foreign currency translation | (39) | (32) | (75) |
| Total Other Comprehensive Income/(Loss) | (43) | (284) | 1,061 |
| Comprehensive Income | 1,588 | 1,745 | 3,641 |
| Comprehensive Income Attributable to Noncontrolling Interest | 66 | 25 | 17 |
| Comprehensive Income Attributable to BMS | 1,522 | 1,720 | 3,624 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2015 | |||
CONSOLIDATED STATEMENTS OF CASH FLOWS | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 12, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash Flows From Operating Activities: | |||
| Net Earnings | $ 1,631 | 2,029 | 2,580 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||
| Net earnings attributable to noncontrolling interest | (66) | (25) | (17) |
| Depreciation and amortization, net | 376 | 467 | 763 |
| Deferred income taxes | (347) | (542) | (491) |
| Stock-based compensation | 235 | 213 | 191 |
| Impairment charges | 192 | 401 | 40 |
| Pension settlements and amortization | 245 | 971 | 294 |
| Other adjustments | 594 | (567) | (9) |
| Changes in operating assets and liabilities: | |||
| Receivables | (942) | (252) | (504) |
| Inventories | 97 | (254) | (45) |
| Accounts payable | (919) | (44) | 412 |
| Deferred income | 218 | 613 | 965 |
| Income taxes payable | 47 | 171 | 126 |
| Other | 471 | (33) | (760) |
| Net Cash Provided by Operating Activities | 1,832 | 3,148 | 3,545 |
| Cash Flows From Investing Activities: | |||
| Sale and maturities of marketable securities | 2,794 | 4,095 | 1,815 |
| Purchase of marketable securities | (3,143) | (5,719) | (1,859) |
| Capital expenditures | (820) | (526) | (537) |
| Divestiture and other proceeds | 708 | 3,585 | 9 |
| Acquisition and other payments | (1,111) | (219) | |
| Net Cash Provided by/(Used in) Investing Activities | (1,572) | 1,216 | (572) |
| Cash Flows From Financing Activities: | |||
| Short-term borrowings, net | (449) | 244 | 198 |
| Issuance of long-term debt | 1,268 | 1,489 | |
| Repayment of long-term debt | (1,957) | (676) | (597) |
| Interest rate swap contract terminations | (2) | 105 | 20 |
| Issuance of common stock | 266 | 288 | 564 |
| Repurchase of common stock | (433) | ||
| Dividends | (2,477) | (2,398) | (2,309) |
| Net Cash Used in Financing Activities | (3,351) | (2,437) | (1,068) |
| Effect of Exchange Rates on Cash and Cash Equivalents | (95) | 58 | 25 |
| Increase/(Decrease) in Cash and Cash Equivalents | (3,186) | 1,985 | 1,930 |
| Cash and Cash Equivalents at Beginning of Year | 5,571 | 3,586 | |
| Cash and Cash Equivalents at End of Year | 2,385 | 5,571 | 3,586 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2015 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 12, 2016) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 2,385 | 5,571 |
| Marketable securities, current | 1,885 | 1,864 |
| Receivables | 4,299 | 3,390 |
| Inventories | 1,221 | 1,560 |
| Deferred income taxes, current | 1,644 | |
| Prepaid expenses and other | 491 | 470 |
| Assets held-for-sale | 134 | 109 |
| Total Current Assets | 10,415 | 14,608 |
| Property, plant and equipment | 4,412 | 4,417 |
| Goodwill | 6,881 | 7,027 |
| Other intangible assets | 1,419 | 1,753 |
| Deferred income taxes | 2,844 | 915 |
| Marketable securities, noncurrent | 4,660 | 4,408 |
| Other assets | 1,117 | 621 |
| Total Assets | 31,748 | 33,749 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings | 139 | 590 |
| Accounts payable | 1,565 | 2,487 |
| Accrued expenses | 2,759 | 2,459 |
| Deferred income, current | 1,003 | 1,167 |
| Accrued rebates and returns | 1,324 | 851 |
| Income taxes payable, current | 572 | 262 |
| Dividends payable | 655 | 645 |
| Total Current Liabilities | 8,017 | 8,461 |
| Pension, postretirement, and postemployment liabilities | 949 | 1,115 |
| Deferred income, noncurrent | 586 | 770 |
| Income taxes payable, noncurrent | 742 | 560 |
| Other liabilities | 480 | 618 |
| Long-term debt | 6,550 | 7,242 |
| Total Liabilities | 17,324 | 18,766 |
| Commitments and contingencies (Note 22) | ||
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 4,161 in 2015 and 4,212 in 2014, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2015 and 2014 | 221 | 221 |
| Capital in excess of par value of stock | 1,459 | 1,507 |
| Accumulated other comprehensive loss | (2,468) | (2,425) |
| Retained earnings | 31,613 | 32,541 |
| Less cost of treasury stock - 539 million common shares in 2015 and 547 million in 2014 | (16,559) | (16,992) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 14,266 | 14,852 |
| Noncontrolling interest | 158 | 131 |
| Total Equity | 14,424 | 14,983 |
| Total Liabilities and Equity | 31,748 | 33,749 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |